Cure My Disease

Don't miss your cure!

 Log in / Sign up

Personalized tablet activities may boost brain training in seniors with mild cognitive impairment

NCT ID NCT03292705

Completed Symptom relief Sponsor: University of Rochester Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a personalized computer program (PEP) could improve attitudes toward technology and engagement with cognitive training in 49 older adults with mild cognitive impairment living in senior communities. Participants first used PEP or a control activity for 4 weeks, then all completed 6 weeks of standard cognitive training. The goal was to see if personalized, enjoyable computer use could make subsequent brain training more effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Personalized Engagement Program (PEP) – a tablet-based system with tailored leisure activities
What this could lead to
If it works, this approach could make cognitive training more engaging and effective for older adults with mild memory problems.
What could go wrong
This is a small, early proof-of-concept study with only 49 participants. Results may not apply to everyone, and the benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MILD COGNITIVE IMPAIRMENT

Contacts and locations

Locations

  • Brickstone/Saint John Meadow

    Rochester, New York, 14618, United States

  • River Edge Manor

    Rochester, New York, 14642, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.